Journal Home
Search for

Volume 1, Issue 3, Pages 223-231 (December 2007)


View previous. 2 of 16 View next.

ISFG: Recommendations on biostatistics in paternity testing

David W. Gjertsona, Charles H. Brennerb, Max P. Baurc, Angel Carracedod, Francois Guidete, Juan A. Luquef, Rüdiger Lessigg, Wolfgang R. Mayrh, Vince L. Pascalii, Mechthild Prinzj, Peter M. Schneiderk, Niels MorlinglCorresponding Author Informationemail address

Received 23 June 2007; accepted 27 June 2007. published online 07 August 2007.

Abstract 

The Paternity Testing Commission (PTC) of the International Society for Forensic Genetics has taken up the task of establishing the biostatistical recommendations in accordance with the ISO 17025 standards and a previous set of ISFG recommendations specific to the genetic investigations in paternity cases. In the initial set, the PTC recommended that biostatistical evaluations of paternity are based on a likelihood ratio principle – yielding the paternity index, PI. Here, we have made five supplementary biostatistical recommendations. The first recommendation clarifies and defines basic concepts of genetic hypotheses and calculation concerns needed to produce valid PIs. The second and third recommendations address issues associated with population genetics (allele probabilities, Y-chromosome markers, mtDNA, and population substructuring) and special circumstances (deficiency/reconstruction and immigration cases), respectively. The fourth recommendation considers strategies regarding genetic evidence against paternity. The fifth recommendation covers necessary documentation, reporting details and assumptions underlying calculations. The PTC strongly suggests that these recommendations should be adopted by all laboratories involved in paternity testing as the basis for their biostatistical analysis.

a Department of Biostatistics, UCLA School of Public Health, Box 951772, Los Angeles, CA 90095-1772, USA

b 6801 Thornhill Drive, Oakland, CA 94611-1336, USA

c Institute of Medical Biometry, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany

d Institute of Legal Medicine, University of Santiago de Compostela, E-15705 Santiago de Compostela, Spain

e Institut Genetique Nantes Atlantique, 19 rue Leon Durocher, BP 70425, F-44204 Nantes Cedex 2, France

f Instituto Nacional de Toxicología y Ciencias Forenses, Servicio de Biología, Ministerio de Justicia. Merced 1, E-08002 Barcelona, Spain

g Institute of Legal Medicine, University of Leipzig, Johannisallee 28, D-04103 Leipzig, Germany

h University Clinic for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, A-1090 Vienna, Austria

i Istituto di medicina legale, Università Cattolica, Largo Francesco Vito, I-100168 Roma, Italy

j Office of the Chief Medical Examiner, Department of Forensic Biology, 520 First Avenue, New York, NY 10016, USA

k Institute of Legal Medicine, University of Cologne, D-50823 Köln, Germany

l Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, 11 Frederik V's Vej, DK-2100 Copenhagen Ø, Denmark

Corresponding Author InformationCorresponding author. Tel.: +45 35 32 61 13; fax: +45 35 32 62 70.

PII: S1872-4973(07)00102-0

doi:10.1016/j.fsigen.2007.06.006


View previous. 2 of 16 View next.